| NCT04015336 |
E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT04015336 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-04-28 |
| NCT03874572 |
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth |
https://ClinicalTrials.gov/show/NCT03874572 |
Active, not recruiting |
Rigshospitalet, Denmark |
2020-06-22 |
| NCT03383094 |
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT03383094 |
Recruiting |
University of California, San Diego |
2021-04-30 |
| NCT03346915 |
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention |
https://ClinicalTrials.gov/show/NCT03346915 |
Completed |
Boston Medical Center |
2019-04-19 |
| NCT03822897 |
De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03822897 |
Recruiting |
Canadian Cancer Trials Group |
2023-12-31 |
| NCT03302676 |
The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors |
https://ClinicalTrials.gov/show/NCT03302676 |
Completed |
Odense University Hospital |
2018-09-30 |
| NCT03258008 |
Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03258008 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-06-30 |
| NCT03226613 |
New Modalities for Detection of Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03226613 |
Completed |
Vanderbilt University Medical Center |
2018-06-06 |
| NCT03224000 |
Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03224000 |
Recruiting |
M.D. Anderson Cancer Center |
2025-01-31 |
| NCT03215719 |
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT03215719 |
Recruiting |
NYU Langone Health |
2020-04-30 |
| NCT03210103 |
Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03210103 |
Recruiting |
Lawson Health Research Institute |
2028-08-15 |
| NCT03096808 |
Adaptive Radiotherapy for Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT03096808 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-03-15 |
| NCT03082534 |
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03082534 |
Recruiting |
University of California, San Diego |
2019-12-30 |
| NCT03077243 |
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC |
https://ClinicalTrials.gov/show/NCT03077243 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2022-08-31 |
| NCT03074110 |
Isocapnic Hyperventilation - an Alternative Method |
https://ClinicalTrials.gov/show/NCT03074110 |
Completed |
Sahlgrenska University Hospital, Sweden |
2017-08-15 |
| NCT03049280 |
Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study |
https://ClinicalTrials.gov/show/NCT03049280 |
Completed |
Intuitive Surgical |
2017-11-14 |
| NCT03010813 |
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery |
https://ClinicalTrials.gov/show/NCT03010813 |
Completed |
Chinese University of Hong Kong |
2017-10-31 |
| NCT02984410 |
Study Assessing The “Best of” Radiotherapy vs the “Best of” Surgery in Patients With Oropharyngeal Carcinoma |
https://ClinicalTrials.gov/show/NCT02984410 |
Recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2020-11-30 |
| NCT02981862 |
CaptHPV : Validation of the Method “CaptHPV” for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas |
https://ClinicalTrials.gov/show/NCT02981862 |
Completed |
Institut de Cancérologie de Lorraine |
2018-06-12 |
| NCT02945631 |
Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT02945631 |
Recruiting |
Icahn School of Medicine at Mount Sinai |
2023-04-30 |
| NCT02908477 |
Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT02908477 |
Recruiting |
Mayo Clinic |
2024-09-15 |
| NCT02792322 |
A Pilot Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck |
https://ClinicalTrials.gov/show/NCT02792322 |
Recruiting |
Mayo Clinic |
2020-05-31 |
| NCT02757222 |
Dose Escalation Versus Standard in Laryngopharyngeal Cancers |
https://ClinicalTrials.gov/show/NCT02757222 |
Recruiting |
Tata Medical Center |
2020-12-31 |
| NCT02703493 |
Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02703493 |
Active, not recruiting |
Northwell Health |
2020-02-01 |
| NCT02586207 |
Pembrolizumab in Combination With CRT for LA-SCCHN |
https://ClinicalTrials.gov/show/NCT02586207 |
Active, not recruiting |
Sanford Health |
2020-06-30 |
| NCT02558803 |
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 |
https://ClinicalTrials.gov/show/NCT02558803 |
Completed |
Regenstrief Institute, Inc. |
2016-05-31 |
| NCT02551887 |
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts |
https://ClinicalTrials.gov/show/NCT02551887 |
Completed |
Regenstrief Institute, Inc. |
2015-04-30 |
| NCT02412241 |
Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients |
https://ClinicalTrials.gov/show/NCT02412241 |
Active, not recruiting |
Vanderbilt-Ingram Cancer Center |
2020-02-29 |
| NCT02338102 |
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02338102 |
Completed |
University of Kansas Medical Center |
2015-05-31 |
| NCT02281955 |
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study |
https://ClinicalTrials.gov/show/NCT02281955 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2019-11-30 |
| NCT02280811 |
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers |
https://ClinicalTrials.gov/show/NCT02280811 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-06-28 |
| NCT02277548 |
A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck. |
https://ClinicalTrials.gov/show/NCT02277548 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2018-04-30 |
| NCT02258659 |
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02258659 |
Active, not recruiting |
University of Chicago |
2018-12-31 |
| NCT02254278 |
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02254278 |
Active, not recruiting |
NRG Oncology |
2019-06-10 |
| NCT02215265 |
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) |
https://ClinicalTrials.gov/show/NCT02215265 |
Recruiting |
Velindre NHS Trust |
2026-10-31 |
| NCT02177838 |
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT02177838 |
Recruiting |
Rutgers, The State University of New Jersey |
2020-06-01 |
| NCT02159703 |
A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT02159703 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2018-02-28 |
| NCT02123511 |
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02123511 |
Completed |
Mayo Clinic |
2016-03-22 |
| NCT01316757 |
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer |
https://ClinicalTrials.gov/show/NCT01316757 |
Completed |
Fox Chase Cancer Center |
2015-04-07 |
| NCT02048020 |
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer |
https://ClinicalTrials.gov/show/NCT02048020 |
Completed |
Jonsson Comprehensive Cancer Center |
2017-01-09 |
| NCT02035527 |
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT02035527 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-04-20 |
| NCT03174275 |
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03174275 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2021-09-01 |
| NCT03258554 |
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin |
https://ClinicalTrials.gov/show/NCT03258554 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT01984359 |
HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01984359 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2015-12-31 |
| NCT01898494 |
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT01898494 |
Active, not recruiting |
Eastern Cooperative Oncology Group |
2020-02-29 |
| NCT01893307 |
Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck |
https://ClinicalTrials.gov/show/NCT01893307 |
Recruiting |
M.D. Anderson Cancer Center |
2023-08-31 |
| NCT01884259 |
Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN |
https://ClinicalTrials.gov/show/NCT01884259 |
Active, not recruiting |
Arbeitsgemeinschaft medikamentoese Tumortherapie |
2021-01-31 |
| NCT01874587 |
Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma |
https://ClinicalTrials.gov/show/NCT01874587 |
Active, not recruiting |
Center Eugene Marquis |
2020-10-31 |
| NCT01810913 |
Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01810913 |
Active, not recruiting |
National Cancer Institute (NCI) |
2027-01-01 |
| NCT01806675 |
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy |
https://ClinicalTrials.gov/show/NCT01806675 |
Completed |
Stanford University |
2016-12-07 |
| NCT01733797 |
Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients |
https://ClinicalTrials.gov/show/NCT01733797 |
Completed |
The Christie NHS Foundation Trust |
2015-08-31 |
| NCT01711541 |
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01711541 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-02-15 |
| NCT01706939 |
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT01706939 |
Active, not recruiting |
Icahn School of Medicine at Mount Sinai |
2021-12-31 |
| NCT01695122 |
Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01695122 |
Completed |
Instituto do Cancer do Estado de São Paulo |
2014-11-30 |
| NCT01663259 |
Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients |
https://ClinicalTrials.gov/show/NCT01663259 |
Completed |
University of Michigan Rogel Cancer Center |
2019-09-30 |
| NCT01637194 |
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01637194 |
Completed |
Fox Chase Cancer Center |
2011-07-31 |
| NCT01590355 |
A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR) |
https://ClinicalTrials.gov/show/NCT01590355 |
Active, not recruiting |
Lawson Health Research Institute |
2021-06-30 |
| NCT01585428 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers |
https://ClinicalTrials.gov/show/NCT01585428 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-04-09 |
| NCT01530997 |
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca |
https://ClinicalTrials.gov/show/NCT01530997 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2014-11-30 |
| NCT01504932 |
Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors |
https://ClinicalTrials.gov/show/NCT01504932 |
Completed |
Ohio State University Comprehensive Cancer Center |
2015-04-22 |
| NCT01469429 |
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. |
https://ClinicalTrials.gov/show/NCT01469429 |
Completed |
Ohio State University Comprehensive Cancer Center |
2014-09-17 |
| NCT01440270 |
Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT01440270 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2014-10-31 |
| NCT01435252 |
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab |
https://ClinicalTrials.gov/show/NCT01435252 |
Completed |
University of Zurich |
2017-10-25 |
| NCT01434394 |
Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT01434394 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2014-10-31 |
| NCT01365169 |
Post-op Wellness Program for Pancreatic Cancer Patients That Uses Patient Feedback and Real-time Provider Monitoring |
https://ClinicalTrials.gov/show/NCT01365169 |
Recruiting |
M.D. Anderson Cancer Center |
2025-02-25 |
| NCT01334177 |
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck |
https://ClinicalTrials.gov/show/NCT01334177 |
Completed |
University of Washington |
2014-06-30 |
| NCT04287868 |
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies |
https://ClinicalTrials.gov/show/NCT04287868 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-07-30 |
| NCT04277858 |
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer. |
https://ClinicalTrials.gov/show/NCT04277858 |
Recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2023-08-31 |
| NCT04178174 |
Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT04178174 |
Recruiting |
Centre hospitalier de l’Université de Montréal (CHUM) |
2023-12-31 |
| NCT04124198 |
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04124198 |
Recruiting |
Rigshospitalet, Denmark |
2024-01-31 |
| NCT04116047 |
CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) |
https://ClinicalTrials.gov/show/NCT04116047 |
Recruiting |
University of Birmingham |
2023-01-31 |
| NCT04112940 |
Physiological Flow of Liquids in Head and Neck Cancer Patients: A Pilot Study |
https://ClinicalTrials.gov/show/NCT04112940 |
Active, not recruiting |
University Health Network, Toronto |
2019-12-31 |
| NCT04106362 |
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT04106362 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2021-07-01 |
| NCT04085120 |
Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain |
https://ClinicalTrials.gov/show/NCT04085120 |
Recruiting |
All India Institute of Medical Sciences, New Delhi |
2020-01-31 |
| NCT04019548 |
Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy |
https://ClinicalTrials.gov/show/NCT04019548 |
Recruiting |
Jules Bordet Institute |
2023-04-01 |
| NCT04012502 |
De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations |
https://ClinicalTrials.gov/show/NCT04012502 |
Recruiting |
Fudan University |
2019-07-01 |
| NCT04001413 |
Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients |
https://ClinicalTrials.gov/show/NCT04001413 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2024-09-30 |
| NCT03838263 |
Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT03838263 |
Recruiting |
UNICANCER |
2020-12-31 |
| NCT03799445 |
Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03799445 |
Recruiting |
M.D. Anderson Cancer Center |
2022-08-01 |
| NCT03735745 |
Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH) |
https://ClinicalTrials.gov/show/NCT03735745 |
Recruiting |
Medical University of South Carolina |
2020-12-30 |
| NCT03729518 |
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck |
https://ClinicalTrials.gov/show/NCT03729518 |
Recruiting |
Abramson Cancer Center of the University of Pennsylvania |
2022-10-11 |
| NCT03715946 |
Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT03715946 |
Recruiting |
University of Pittsburgh |
2021-05-31 |
| NCT03713021 |
TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers |
https://ClinicalTrials.gov/show/NCT03713021 |
Recruiting |
Washington University School of Medicine |
2021-05-31 |
| NCT03691441 |
Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03691441 |
Recruiting |
Universitätsklinikum Hamburg-Eppendorf |
2023-06-05 |
| NCT03656133 |
Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers |
https://ClinicalTrials.gov/show/NCT03656133 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2021-08-30 |
| NCT03618134 |
Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner |
https://ClinicalTrials.gov/show/NCT03618134 |
Recruiting |
Jonsson Comprehensive Cancer Center |
2022-10-01 |
| NCT03604588 |
Evaluation of HPV OncoTect â„¢ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers |
https://ClinicalTrials.gov/show/NCT03604588 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2019-01-31 |
| NCT03435471 |
Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT03435471 |
Active, not recruiting |
University of Miami |
2020-08-31 |
| NCT03427411 |
M7824 in Subjects With HPV Associated Malignancies |
https://ClinicalTrials.gov/show/NCT03427411 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT03422536 |
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT03422536 |
Recruiting |
University of Arizona |
2020-12-31 |
| NCT03416153 |
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT03416153 |
Recruiting |
University of Michigan Rogel Cancer Center |
2021-11-21 |
| NCT01173692 |
Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. |
https://ClinicalTrials.gov/show/NCT01173692 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-07-01 |
| NCT01155609 |
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT01155609 |
Completed |
University of Washington |
2011-12-31 |
| NCT01108042 |
TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer |
https://ClinicalTrials.gov/show/NCT01108042 |
Completed |
University of Jena |
2016-01-31 |
| NCT01064921 |
Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma |
https://ClinicalTrials.gov/show/NCT01064921 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-11-08 |
| NCT01044433 |
Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck |
https://ClinicalTrials.gov/show/NCT01044433 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2015-09-24 |
| NCT01032928 |
Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT01032928 |
Completed |
VA Office of Research and Development |
2013-07-31 |
| NCT00939627 |
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab |
https://ClinicalTrials.gov/show/NCT00939627 |
Completed |
National Cancer Institute (NCI) |
2013-01-31 |
| NCT03418792 |
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx |
https://ClinicalTrials.gov/show/NCT03418792 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2021-03-31 |
| NCT04162873 |
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT04162873 |
Recruiting |
University of Utah |
2024-10-12 |
| NCT02953197 |
18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours |
https://ClinicalTrials.gov/show/NCT02953197 |
Completed |
Guy’s and St Thomas’ NHS Foundation Trust |
2018-01-31 |
| NCT03952585 |
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT03952585 |
Recruiting |
National Cancer Institute (NCI) |
2025-02-28 |
| NCT03811015 |
Testing Maintenance Immunotherapy Versus Observation in Patients With Oropharynx Cancer |
https://ClinicalTrials.gov/show/NCT03811015 |
Recruiting |
National Cancer Institute (NCI) |
2027-01-01 |
| NCT03423264 |
PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing |
https://ClinicalTrials.gov/show/NCT03423264 |
Recruiting |
University of Chicago |
2020-06-01 |
| NCT00780312 |
Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00780312 |
Completed |
Rigshospitalet, Denmark |
2012-03-31 |
| NCT00721799 |
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients |
https://ClinicalTrials.gov/show/NCT00721799 |
Completed |
University of Iowa |
2014-12-31 |
| NCT00492089 |
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00492089 |
Completed |
National Cancer Institute (NCI) |
2010-08-31 |
| NCT00513435 |
Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00513435 |
Completed |
National Cancer Institute (NCI) |
2011-03-31 |
| NCT00507767 |
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00507767 |
Completed |
National Cancer Institute (NCI) |
2010-02-28 |
| NCT00490282 |
A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00490282 |
Completed |
M.D. Anderson Cancer Center |
2015-05-31 |
| NCT00486304 |
Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00486304 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2007-02-28 |
| NCT00473564 |
Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery |
https://ClinicalTrials.gov/show/NCT00473564 |
Completed |
University of Alabama at Birmingham |
2013-12-31 |
| NCT00470496 |
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00470496 |
Completed |
Roswell Park Cancer Institute |
2011-10-28 |
| NCT00410826 |
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00410826 |
Completed |
University of Washington |
2012-05-31 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00387335 |
Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00387335 |
Completed |
National Cancer Institute (NCI) |
2010-03-31 |
| NCT00330382 |
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia |
https://ClinicalTrials.gov/show/NCT00330382 |
Completed |
National Cancer Institute (NCI) |
2010-07-31 |
| NCT00162708 |
Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC |
https://ClinicalTrials.gov/show/NCT00162708 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
NA |
| NCT00158678 |
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC |
https://ClinicalTrials.gov/show/NCT00158678 |
Completed |
Groupe Oncologie Radiotherapie Tete et Cou |
2020-03-22 |
| NCT00158652 |
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC |
https://ClinicalTrials.gov/show/NCT00158652 |
Completed |
Groupe Oncologie Radiotherapie Tete et Cou |
2011-03-31 |
| NCT00114283 |
Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00114283 |
Completed |
National Cancer Institute (NCI) |
2006-10-31 |
| NCT00103259 |
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00103259 |
Completed |
National Cancer Institute (NCI) |
2011-11-30 |
| NCT00101348 |
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00101348 |
Completed |
National Cancer Institute (NCI) |
2007-10-31 |
| NCT00098631 |
Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00098631 |
Completed |
National Cancer Institute (NCI) |
2006-12-31 |
| NCT00096512 |
S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00096512 |
Completed |
National Cancer Institute (NCI) |
2006-05-31 |
| NCT00095628 |
SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00095628 |
Completed |
National Cancer Institute (NCI) |
2010-07-31 |
| NCT00089362 |
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors |
https://ClinicalTrials.gov/show/NCT00089362 |
Completed |
National Cancer Institute (NCI) |
2008-01-31 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00068497 |
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00068497 |
Completed |
National Cancer Institute (NCI) |
2007-12-31 |
| NCT00064103 |
Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx |
https://ClinicalTrials.gov/show/NCT00064103 |
Completed |
National Cancer Institute (NCI) |
2007-08-31 |
| NCT00063895 |
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00063895 |
Completed |
National Cancer Institute (NCI) |
2005-10-31 |
| NCT00055913 |
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00055913 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00055770 |
Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00055770 |
Completed |
National Cancer Institute (NCI) |
2006-12-31 |
| NCT00049283 |
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00049283 |
Completed |
National Cancer Institute (NCI) |
2008-02-29 |
| NCT00049166 |
Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer |
https://ClinicalTrials.gov/show/NCT00049166 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00033618 |
Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck |
https://ClinicalTrials.gov/show/NCT00033618 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00030498 |
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction |
https://ClinicalTrials.gov/show/NCT00030498 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00023959 |
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00023959 |
Completed |
National Cancer Institute (NCI) |
2010-03-31 |
| NCT00006360 |
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer |
https://ClinicalTrials.gov/show/NCT00006360 |
Completed |
Radiation Therapy Oncology Group |
2005-11-30 |